Meningococcal Surveillance Australia Reporting period 1 October to 31 December 2022
DOI:
https://doi.org/10.33321/cdi.2023.47.23Keywords:
antimicrobial resistance, disease surveillance, meningococcal disease, Neisseria meningitidisAbstract
The Australian National Neisseria Network (NNN) comprises reference laboratories in each state and territory that report data on antimicrobial susceptibility testing to an agreed group of antimicrobial agents for the Australian Meningococcal Surveillance Programme (AMSP). This report presents national meningococcal antimicrobial resistance surveillance data for the indicated quarter.
Downloads
References
Australian Government Department of Health and Aged Care, Communicable Diseases Network Australia (CDNA). Invasive Meningococcal Disease: CDNA National Guidelines for Public Health Units. Canberra: Australian Government Department of Health and Aged Care; 4 July 2017. Available from: https://www.health.gov.au/sites/default/files/documents/2020/02/invasive-meningococcal-disease-cdna-national-guidelines-for-public-health-units.pdf.
Lahra MM, Shoushtari M, Hogan TR. Meningococcal Surveillance Australia: Reporting period 1 October to 31 December 2020. Commun Dis Intell (2018). 2021:45. doi: https://doi.org/10.33321/cdi.2021.45.36.
Lahra MM, George RCR, Hogan TR. Australian Meningococcal Surveillance Programme Annual Report, 2021. Commun Dis Intell (2018). 2022:46. doi: https://doi.org/10.33321/cdi.2022.46.46.
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 Communicable Diseases Intelligence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
